India Reviews Weight-Loss Drugs Amid Demand Surge
India Orders Safety Review of Weight-Loss Drugs Amid Demand Surge
Key Highlights
India increases vigilance on weight-loss drugs as demand surges. The Pharmacopoeia Commission will compile adverse event reports to ensure consumer safety.
Indian authorities are escalating their oversight of widely used weight loss medications in response to increasing demand. The Indian Pharmacopoeia Commission is set to compile reports on any adverse events linked to these drugs.
The move aims to ensure the safety of consumers and facilitate timely regulatory action. As generic versions of these drugs are anticipated to become readily accessible soon, the need for vigilance has grown.
In related efforts, regulatory bodies are intensifying their crackdown on misleading advertisements associated with prescription medicines, ensuring that consumers receive accurate and reliable information.